The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects

Megan V. Cannon, Hongjuan Yu, Wellington M. Candido, Martin M. Dokter, Eva-Lotte Lindstedt, Herman H. W. Sillje, Wiek H. van Gilst, Rudolf A. de Boer*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases